1. Home
  2. AWH vs OXBR Comparison

AWH vs OXBR Comparison

Compare AWH & OXBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AWH
  • OXBR
  • Stock Information
  • Founded
  • AWH 1993
  • OXBR 2013
  • Country
  • AWH United States
  • OXBR Cayman Islands
  • Employees
  • AWH N/A
  • OXBR N/A
  • Industry
  • AWH Medical/Dental Instruments
  • OXBR Property-Casualty Insurers
  • Sector
  • AWH Health Care
  • OXBR Finance
  • Exchange
  • AWH Nasdaq
  • OXBR Nasdaq
  • Market Cap
  • AWH 13.5M
  • OXBR 15.8M
  • IPO Year
  • AWH N/A
  • OXBR 2014
  • Fundamental
  • Price
  • AWH $0.75
  • OXBR $2.74
  • Analyst Decision
  • AWH Buy
  • OXBR
  • Analyst Count
  • AWH 2
  • OXBR 0
  • Target Price
  • AWH $4.40
  • OXBR N/A
  • AVG Volume (30 Days)
  • AWH 139.7K
  • OXBR 14.1K
  • Earning Date
  • AWH 11-14-2024
  • OXBR 11-13-2024
  • Dividend Yield
  • AWH N/A
  • OXBR N/A
  • EPS Growth
  • AWH N/A
  • OXBR N/A
  • EPS
  • AWH N/A
  • OXBR N/A
  • Revenue
  • AWH $8,923,000.00
  • OXBR N/A
  • Revenue This Year
  • AWH $15.56
  • OXBR N/A
  • Revenue Next Year
  • AWH $105.32
  • OXBR N/A
  • P/E Ratio
  • AWH N/A
  • OXBR N/A
  • Revenue Growth
  • AWH N/A
  • OXBR N/A
  • 52 Week Low
  • AWH $0.72
  • OXBR $0.87
  • 52 Week High
  • AWH $5.65
  • OXBR $3.72
  • Technical
  • Relative Strength Index (RSI)
  • AWH 33.23
  • OXBR 52.49
  • Support Level
  • AWH $0.84
  • OXBR $2.41
  • Resistance Level
  • AWH $0.87
  • OXBR $2.97
  • Average True Range (ATR)
  • AWH 0.09
  • OXBR 0.22
  • MACD
  • AWH -0.02
  • OXBR -0.01
  • Stochastic Oscillator
  • AWH 12.87
  • OXBR 55.93

About AWH Aspira Women's Health Inc.

Aspira Womens Health Inc is engaged in developing and commercializing diagnostic tests for gynecologic diseases. Its products include OvaSuite which is a portfolio of blood tests that applies proprietary algorithms incorporating patient features; OvaWatch intended for use in assessing the risk of ovarian cancer for women with adnexal masses; and Ova1Plus is a portfolio of blood tests, Ova1Plus is a combination of two FDA-cleared tests for women with pelvic masses who are planned for surgery.

About OXBR Oxbridge Re Holdings Limited

Oxbridge Re Holdings Ltd is a specialty property and casualty reinsurer. It provides reinsurance solutions through its subsidiary. It focuses on underwriting fully collateralized reinsurance contracts primarily for property and casualty insurance companies in the Gulf Coast region of the United States, with an emphasis on Florida. Oxbridge specializes in underwriting medium frequency, high severity risks, where insufficient data exists to analyze effectively the risk/return profile of reinsurance contracts. The Company manages its business on the basis of one operating segment, Property and Casualty Reinsurance.

Share on Social Networks: